BioPharma Services Completes Successful Inspection by the World Health Organization (WHO)
[TORONTO, July 17, 2023] — BioPharma Services, a leading Clinical Research Organization (CRO) globally renowned for advancing healthcare through clinical studies, recently completed a comprehensive inspection conducted by the World Health Organization (WHO) and Health Canada.
This pivotal evaluation, which began on July 10th, underscored our ongoing commitment to the highest standards in clinical research and confirmed that our operational methods align with global best practices.
The WHO conducted a full inspection of our processes and research procedures. The inspection also included an examination of our Bioanalytical Laboratories and clinic. The objective was to certify the reliability and integrity of our work, further validating our commitment to maintaining the highest international standards in clinical research.
Vaideki Dharmaratnam, Senior Director, Global Quality Assurance noted “We welcomed the WHO inspection as a great opportunity to confirm the quality of BioPharma Services processes/systems and our unwavering commitment to ethical research practices”.
We are very pleased that the inspection has affirmed our rigorous standards for conducting clinical trials, and we will continue our mission to drive drug development forward with integrity, quality, and transparency. Our commitment remains to service all our communities with high quality research to enable safe and effective medications to patients in need.” commented Anna Taylor, Managing Director at BioPharma Services.
BioPharma Services remains dedicated to conducting research that meets the stringent requirements of health organizations worldwide. We continuously strive for improvements in the quality of our services and acknowledge the role of the WHO in helping us achieve this mission.
The outcomes of the WHO inspection have been shared with our stakeholders, partners, and the public, underlining our promise of transparency and the consistent delivery of top-tier research.
Review BioPharma’s Full Regulatory History Here.
About BioPharma Services Inc.
BioPharma Services Inc. is a full-service Contract Research Organization (CRO) specializing in the conduct of Phase 1/2a and Bioequivalence clinical trials for international pharmaceutical companies worldwide. BioPharma Services has clinical research facilities both in the USA and Canada with a total capacity of 300 beds with access to healthy volunteers and special populations. Headquartered in Toronto, Canada, BioPharma’s comprehensive services also include Bioanalysis at our GLP Certified Laboratory, Scientific and Regulatory Affairs, Biostatistics and Safety Data Analysis (CDISC), Data Management and Medical Writing. For more information about BioPharma Services, please contact Thomas Willoughby, Commercial Operations Vice President, Business Development at twilloughby@biopharmaservices.com
